Dr. Gregory R. Blaha, MD, PhD

Dr. Blaha practices at Gurley Eye Care Associates in Manchester, Massachusetts.

Dr. Blaha's NPI, 1902998776, was assigned on September 29, 2006. Dr. Blaha graduated from Perelman School of Medicine - Philadelphia in 2000. Dr. Blaha holds Massachusetts license 221050.

Dr. Blaha's primary practice is Gurley Eye Care Associates, at 195 School St Suite B Suite B, Manchester, MA 01944-1704. The practice phone is (978) 526-4800.

Dr. Blaha's primary practice is Gurley Eye Care Associates in Manchester, Massachusetts. Dr. Blaha is also affiliated with Beth Israel Deaconess Medical Center. The medical group on file is Lahey Clinic. Dmand AI also links Dr. Blaha to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blaha practices, 6 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Blaha's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Blaha is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Blaha's licenses on file in 3 states: Massachusetts, New Hampshire and Pennsylvania.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, dry eye, eyelid inflammation, glaucoma and inflammation of iris among the conditions Dr. Blaha treats.

CMS data shows 9,716 Medicare services from Dr. Blaha across 17 procedure codes in 2024, for 938 Medicare patients. Medicare paid $429,685 for them.

CMS counts 938 Medicare patients who saw Dr. Blaha in 2024. The largest group is 75 to 84, with 376 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Blaha's median patient age at 76, with 57% women.

In 2024, Dr. Blaha wrote 580 Medicare Part D claims for 166 patients. 63% of them were for generic drugs. CMS names the drug for 545 of them, across 9 drugs with 11 or more claims each, at $20,797 in total drug cost. In 2023, CMS named 391 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Blaha for performance year 2024, reported through an alternative payment model (APM). Dr. Blaha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 54 procedures of cataract surgery by Dr. Blaha, more than 65% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Blaha, published from 2009 to 2024. 2021 was the busiest year, with 2. The most frequent topics are Vitreous Body, Antibodies, Monoclonal and Fluorescein Angiography. Dr. Blaha has published most often in Retina. Dr. Blaha's most frequent co-authors are Fina Canas Barouch, MD, Jeffrey L. Marx, MD and Jeffrey Chang, MD.

Dmand AI links Dr. Blaha to 1 clinical trial. Conditions studied include Macular Degeneration and Retinal Degeneration.

CMS Open Payments shows 32 general payments to Dr. Blaha from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 53% of the total. Beaver-Visitec International, Inc. paid the most, $1,350.

Dmand AI lists 1 award for Dr. Blaha.

Dr. Blaha graduated from Perelman School of Medicine - Philadelphia in 2000. Dr. Blaha is a member of AAO.

Dr. Blaha is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.